SUD patients, have also ask for the integration of PREM items in the survey and more specific questions regarding their health status
It is unknown whether TRULICITY causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as human relevance of dulaglutide-induced rodent thyroid C-cell tumors has not been determined [see Warnings and Precautions (5.1), and Nonclinical Toxicology (13.1)]
30 Although daytime fatigue and sleepiness are common complaints, the expected level of daytime somnolence is lower than expected for the degree of sleep disturbance, suggesting a degree of hyperarousal in RLS
The medication typically shows a significant reduction in blood sugar levels and improves glycemic control when you use the medication at FDA-approved therapeutic doses (such as 2.5 mg, 5 mg, 10 mg, 12.5 mg, and 15 mg)
Use the 40 mg/mL chart